KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.30 $3.29 Friday, 26th Apr 2024 ABUS stock ended at $2.73. This is 0.368% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 2.21% from a day low at $2.71 to a day high of $2.77.
90 days $2.27 $3.29
52 weeks $1.69 $3.29

Historical Arbutus Biopharma Corporation prices

Date Open High Low Close Volume
Apr 26, 2024 $2.73 $2.77 $2.71 $2.73 400 532
Apr 25, 2024 $2.74 $2.75 $2.68 $2.72 317 967
Apr 24, 2024 $2.75 $2.78 $2.74 $2.75 338 544
Apr 23, 2024 $2.64 $2.75 $2.64 $2.75 1 088 049
Apr 22, 2024 $2.73 $2.74 $2.64 $2.64 728 472
Apr 19, 2024 $2.71 $2.81 $2.65 $2.72 913 603
Apr 18, 2024 $2.78 $2.79 $2.69 $2.73 988 339
Apr 17, 2024 $2.91 $2.94 $2.78 $2.78 680 679
Apr 16, 2024 $2.89 $2.94 $2.88 $2.92 638 738
Apr 15, 2024 $2.90 $2.99 $2.82 $2.97 3 616 986
Apr 12, 2024 $2.99 $3.03 $2.90 $2.91 657 294
Apr 11, 2024 $2.95 $3.05 $2.94 $3.03 832 493
Apr 10, 2024 $3.01 $3.02 $2.90 $2.98 1 104 884
Apr 09, 2024 $3.06 $3.11 $3.00 $3.01 796 742
Apr 08, 2024 $3.17 $3.19 $3.03 $3.09 1 218 381
Apr 05, 2024 $3.02 $3.29 $2.98 $3.12 6 075 330
Apr 04, 2024 $2.93 $3.11 $2.86 $3.00 8 055 108
Apr 03, 2024 $2.51 $3.25 $2.30 $2.92 12 399 405
Apr 02, 2024 $2.52 $2.54 $2.49 $2.52 440 525
Apr 01, 2024 $2.61 $2.61 $2.55 $2.56 480 974
Mar 28, 2024 $2.59 $2.61 $2.55 $2.58 509 565
Mar 27, 2024 $2.49 $2.60 $2.48 $2.60 815 074
Mar 26, 2024 $2.53 $2.53 $2.48 $2.49 368 527
Mar 25, 2024 $2.51 $2.54 $2.49 $2.49 331 415
Mar 22, 2024 $2.55 $2.55 $2.50 $2.50 326 456
Click to get the best stock tips daily for free!

About Arbutus Biopharma Corporation

Arbutus Biopharma Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT